Telehealth Collaborative Care Led by Clinical Pharmacists for People With Psychosis or Bipolar Disorder
Esti Iturralde,Lisa Fazzolari,Natalie E Slama,Stacey E Alexeeff,Stacy A Sterling,Sameer Awsare,Maria T Koshy,Macy Shia,Natalie E. Slama,Stacey E. Alexeeff,Stacy A. Sterling,Maria T. Koshy
DOI: https://doi.org/10.4088/jcp.23m14917
2024-01-29
The Journal of Clinical Psychiatry
Abstract:<b><i>Objective:</i></b> People with psychosis or bipolar disorder (severe and persistent mental illness [SPMI]) are at high risk for poor psychiatric and chronic illness outcomes, which could be ameliorated through improved health care quality. This study assessed whether a telehealth, collaborative care program managed by psychiatric clinical pharmacists (SPMI Population Care) was associated with improved health care quality for adults with SPMI in a large California health system.<b><i>Methods:</i></b> This retrospective cohort study used electronic health record data to compare 968 program enrollees at 6 demonstration sites (Population Care) to 8,339 contemporaneous patients with SPMI at 6 non-program sites (Usual Care). SPMI diagnoses were based on <i>ICD-10-CM</i> diagnostic codes. Primary outcomes were optimal psychotropic medication adherence, guideline-recommended glycemic screening, annual psychiatrist visit, and emergency department use. Difference-in-difference analyses assessed change in outcomes from 12 months pre- to 12 months post-enrollment using overlap weighting with high dimensional propensity scores to balance participant characteristics across groups. Participant data were collected from January 1, 2020, to June 30, 2022.<b><i>Results:</i></b> From pre- to post-enrollment, Population Care was associated with greater achievement of psychotropic medication adherence and glycemic screening (+6 and +9 percentage points), but unexpectedly with a decrease in annual psychiatrist visits (-6 percentage points) and no significant change in emergency department use, relative to Usual Care. More than 75% of Population Care participants attended an intake and ≥ 1 follow-up visits. Participants with psychosis (26% of sample) had similar results as those with bipolar disorder.<b><i>Conclusions:</i></b> Clinical pharmacist-led telehealth collaborative care has potential to improve psychopharmacologic treatment adherence and recommended disease preventive screening for people with psychosis or bipolar disorder.
psychiatry,psychology, clinical